These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16801471)

  • 21. Nitric oxide-releasing aspirin: will it say NO to atherothrombosis?
    Antoniades C; Tousoulis D; Stefanadis C
    Int J Cardiol; 2007 May; 118(2):170-2. PubMed ID: 16997401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [CUtLASS 1 - Increasing disillusion about 2nd generation neuroleptics].
    Steinert T
    Psychiatr Prax; 2007 Jul; 34(5):255-7. PubMed ID: 17607643
    [No Abstract]   [Full Text] [Related]  

  • 23. [Resistance to desaggregants: causes, clinical implication, methods of diagnosis and correction].
    Kremneva LV; Shalaev SV
    Ter Arkh; 2008; 80(12):89-95. PubMed ID: 19227916
    [No Abstract]   [Full Text] [Related]  

  • 24. [Acute nitrate--essential in coronary heart disease].
    MMW Fortschr Med; 2009 Jun; 151(25):48-9. PubMed ID: 19739525
    [No Abstract]   [Full Text] [Related]  

  • 25. Optimal sample size determinations from an industry perspective based on the expected value of information.
    Willan AR
    Clin Trials; 2008; 5(6):587-94. PubMed ID: 19029207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treating essential hypertension. Are beta blockers still first choice?].
    Rahn KH
    MMW Fortschr Med; 2007 May; 149(18):43-5. PubMed ID: 17672414
    [No Abstract]   [Full Text] [Related]  

  • 27. Corporate influence over planning and presentation of clinical trials: beauty and the beast.
    Fuchs FD
    Expert Rev Cardiovasc Ther; 2010 Jan; 8(1):7-9. PubMed ID: 20014930
    [No Abstract]   [Full Text] [Related]  

  • 28. Triple antithrombotic management after stent implantation: when and how?
    Schömig A; Sarafoff N; Seyfarth M
    Heart; 2009 Aug; 95(15):1280-5. PubMed ID: 19605755
    [No Abstract]   [Full Text] [Related]  

  • 29. Importance of realistic sample size calculations and why the next randomized trial needs to be large and multicentered.
    Li TS; Lee A; Joynt GM
    Crit Care Med; 2007 Feb; 35(2):675-6. PubMed ID: 17251734
    [No Abstract]   [Full Text] [Related]  

  • 30. [New antithrombotic drugs in cardiovascular disease].
    Golino P; Cimmino G; Porchetta I; Spadera M; Volpe M; Calabrò R
    G Ital Cardiol (Rome); 2006 Feb; 7(2):109-18. PubMed ID: 16532722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sample size calculation for multicenter randomized trial: taking the center effect into account.
    Vierron E; Giraudeau B
    Contemp Clin Trials; 2007 Jul; 28(4):451-8. PubMed ID: 17188941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical studies with anticoagulants to improve survival in cancer patients.
    Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
    Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergency physician survey: recombinant tissue plasminogen activator for stroke.
    Mann J
    Ann Emerg Med; 2006 Oct; 48(4):476; author reply 477. PubMed ID: 16997689
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Armstrong PW; Cannon CP; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2570-89. PubMed ID: 17502591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Resting heart rate as prognostic parameter--a slow rate indicates strength].
    Füessl HS
    MMW Fortschr Med; 2008 May; 150(21):12-4, 16. PubMed ID: 18575247
    [No Abstract]   [Full Text] [Related]  

  • 37. Substitution of fractionated for unfractionated heparin during high-risk percutaneous coronary intervention: has the problem been solved?
    Eisenberg MJ
    J Am Coll Cardiol; 2007 Jun; 49(23):2247-8. PubMed ID: 17560288
    [No Abstract]   [Full Text] [Related]  

  • 38. [COURAGE: guidelines and realities--a comment].
    Hansen PR
    Ugeskr Laeger; 2007 Jun; 169(23):2228. PubMed ID: 17607850
    [No Abstract]   [Full Text] [Related]  

  • 39. Mega-trials for blockbusters.
    Ioannidis JP
    JAMA; 2013 Jan; 309(3):239-40. PubMed ID: 23321760
    [No Abstract]   [Full Text] [Related]  

  • 40. DUAAL: atorvastatin provided an unexpectedly potent heart benefit in patients with chronic stable angina.
    Cardiovasc J Afr; 2008; 19(3):174. PubMed ID: 18568187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.